Journal of Yeungnam Medical Science

Case report

Purulent pericarditis: subdiaphragmatic suppurative focus: Kang-Un Choi, Chan-Hee Lee; Yeungnam Univ J Med. 2020;37(1):63-66. Published online September 4, 2019; DOI: https://doi.org/10.12701/yujm.2019.00311

5,943 View
96 Download
1 Crossref

Purulent pericarditis is defined as a localized pericardial infection with gross pus formation in the pericardial space. Although purulent pericarditis is now rare in the antibiotic era, it may be life-threatening. We describe a rare case of purulent pericarditis that originated from a subdiaphragmatic suppurative focus in an immunocompromised host.

Citations

Citations to this article as recorded by

A Study on the Process of Posttraumatic Growth among Helping Professionals in Suicide Prevention: Focused on Grounded Theory
Sungkyu Lee, Hyeyeon Sung, Chonghee Seo
Journal of Social Science.2021; 32(3): 149. CrossRef

Original Article

Risk Factors of Nosocomial Bacteremia of Extended-spectrum beta-Lactamase Producing Escherichia coli.: Daisik Ko, Song Mi Moon, Ji Sung Lee, Yoon Soo Park, Yong Kyun Cho; Yeungnam Univ J Med. 2013;30(2):83-89. Published online December 31, 2013; DOI: https://doi.org/10.12701/yujm.2013.30.2.83

2,077 View
5 Download

Abstract PDF: BACKGROUND
The prevalence of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli is increasing rapidly worldwide. Treatment options for ESBL-producing E. coli are limited, and infections caused by this organism are associated with improper antibiotic use, a long hospital stay, and increased mortality. Thus, the assessment and early recognition of the risk factors of nosocomial infections due to ESBL-producing E. coli are important for the infection control and proper treatment. METHODS: A case-control study was performed that included nosocomial episodes of ESBL-producing E. coli bacteremia at a tertiary care hospital from January 2004 to December 2007. For each case patient, three controls were randomly selected and data on predisposing factors were collected. RESULTS: Fifty-five cases of nosocomial ESBL-producing E. coli bacteremia were studied. Carbapenem usage (OR: 11.3, 95% CI: 1.1-115.9, p=0.041), quinolone usage (OR: 4.5, 95% CI: 1.1-18.8, p=0.042), biliary obstructive disease (OR: 11.8, 95% CI: 3.0-46.7, p<0.001) and the APACHE II score (OR: 1.3, 95% CI: 1.2- 1.5, p<0.001) were analyzed as independent risk factors of nosocomial ESBL-producing E. coli bacteremia. CONCLUSION: Our results showed that physicians caring for patients with risk factors of nosocomial bacteremia should consider ESBL-producing E. coli as the causative organisms of the disease.

First
Prev
Page of 1
Next
Last

Search